EFMC Prizes 2015 - Call for Nominations/Applications

To acknowledge and recognize an outstanding young medicinal chemist working in Academia within Europe.

The Prize is given annually to a young medicinal chemist (≤ 10 years after PhD), and consists of a diploma, €1.000 and an invitation to give a short presentation at the  6th EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry (EFMC-ASMC 15), November 2015, Israel.
Two additional nominees will also be identified and acknowledged.

Applications should be done via the application form on www.efmc.info and should consist of:

• a one-page letter by the candidate including a short rationale for their application
• one page with his/her most important publications
• a brief cv of the candidate
• abstract of potential oral presentation

To acknowledge and recognize an outstanding young medicinal chemist working in industry within Europe.

The Prize is given annually to a young medicinal chemist (≤ 10 years after PhD), and consists of a diploma, €1.000 and an invitation to give a short presentation at the 6th EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry (EFMC-ASMC 15), November 2015, Israel.
Two additional nominees will also be identified and acknowledged.

Nominations should be submitted by the candidate's supervisor via the submission form on www.efmc.info and should consist of:

• a letter by the supervisor
• a brief cv of the candidate
• abstract of potential oral presentation

11. Swiss Course on Medicinal Chemistry 2014

This five-day Medicinal Chemistry School, that is organized by the Division of Medicinal Chemistry and Chemical Biology of the Swiss Chemical Society, will focus on most modern aspects associated with small molecule drug discovery, highlighting the relevance of hit generation, lead finding and lead optimization technologies.

Program and CV of the speakers

More details on www.scg.ch/leysin/2014

MipTec 2014: Peptide Therapeutics Forum, Spt 23, 2014

Tuesday, September 23, 2014   
Congress Center Basel, Room 5

The Peptide Therapeutics Forum 2014 will be divided up in a morning session on “Peptide Discovery” and afternoon presentations on “Development of therapeutic Peptides”. The first part provides some insight into latest methodologies for peptide synthesis and interesting projects more from a preclinical perspective. The afternoon session is dedicated to more advanced peptides. Topics to be discussed include intracellular delivery of peptides, diagnostic imaging and specific disease associated themes, e.g. peptides from the Incretin family to treat diabetes & obesity. This event is thought to disseminate information on latest developments in the broad field of therapeutic peptides and to enable networking of interested parties from academia and industries.

Organizers: Thomas Vorherr, Eric Kitas

Link to the forum website.

Link to the Interactive Planner
Please subscribe to our Newsletter so stay informed about the latest updates.

David Spichiger, SCS
05.09.2014

Prof. Karl-Heinz Altmann awarded the Paul Ehrlich Prize 2014

"The French Medicinal Chemistry Society (SCT) and Janssen-Cilag S.A. are very pleased to annonce that the Paul Ehrlich Prize 2014 is attributed to Professor Karl-Heinz ALTMANN (Institut of Pharmaceutical Sciences, ETH Zürich, Switzerland) recognizing his outstanding  contribution  and substantial  results in the field of the chemistry and chemical biology of pharmaceutically relevant natural products and analogs.  

Professor Altmann will deliver a plenary lecture at the 50th International Conference on Medicinal Chemistry (RICT 2014) in Rouen, Normandy, on July 2-4 2014.

For more information on RICT 2014, see: www.sct-asso.fr

The Swiss Chemical Society thanks Prof. Altmann for his outstanding, scientific contributions and contratulates on this honorable award.
Karl-Heinz Altmann is a Member of the SCS divisional board of Medicinal Chemistry & Chemical Biology and was its President from 2011 - 2013.

Website of Prof. Karl-Heinz Altmann, Inst. f. Pharmazeutische Wiss. ,ETH Zürich

David Spichiger, SCS
19.06.2014